Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)

Hong Kong · Delayed Price · Currency is HKD

4.410

-0.930 (-17.42%)

Mar 31, 2025, 4:08 PM HKT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Anti-cancer Drugs	66.64M	Log In
Anti-cancer Drugs Growth	103.03%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
China	66.64M	Log In
China Growth	103.03%	Log In